This company develops a data-driven platform for precision psychiatry, starting with depression treatment. They utilize a next-generation EEG wearable and the Neurotique TM ERP interface to generate objective, brain-based patient classifications called neurotypes. This neurotyping approach translates neuroscience research into functional neural measures, enabling improved patient selectivity and targeted treatment decisions for psychiatric conditions.
Funding
Funding not disclosed
Founders
Product
Problem
Current methods for diagnosing and treating depression often rely on subjective symptom reporting, leading to a one-size-fits-all approach that overlooks the underlying neurological differences between patients. This lack of precision can result in ineffective treatments and delayed recovery.
Solution
Universal Brain offers a neuroscience-based platform that uses EEG and MRI data to identify distinct neurotypes of depression, enabling more precise and personalized treatment strategies. The platform combines a next-generation EEG wearable with a digital ERP interface, providing clinicians with interpretable data about a patient's cognitive and emotional abilities. This data-driven approach supports improved diagnosis, treatment selection, and monitoring of treatment efficacy. For patients, Universal Brain provides a gamified neurofeedback system that modulates brain activity associated with depressive symptoms, offering a dynamic, engaging treatment option.
Target Audience
The primary target audience includes biopharmaceutical companies conducting clinical trials for psychiatric drugs, healthcare providers specializing in mental health, and patients seeking personalized and data-driven treatment options for depression.
Features
- Next-generation EEG wearable device for capturing real-time brain activity data
- Neurotique™ ERP app for analyzing and interpreting EEG data related to cognitive and emotional functions
- Algorithm-driven software for identifying patient-specific neurotypes based on functional brain measures
- Gamified neurofeedback system that provides real-time feedback to patients, modulating brain activity and alleviating depressive symptoms
- Clinician dashboard for accessing patient data, neurotype classifications, and treatment recommendations
- Integration of objective, brain-based measures into clinical drug trials for improved patient selection and outcome prediction